BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taouli B. Diffusion-weighted MR Imaging for Liver Lesion Characterization: A Critical Look. Radiology 2012;262:378-80. [DOI: 10.1148/radiol.11112417] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Herrmann J, Petit P, Grabhorn E, Lenz A, Jürgens J, Franchi-Albella S. Liver cirrhosis in children - the role of imaging in the diagnostic pathway. Pediatr Radiol 2022. [PMID: 36040526 DOI: 10.1007/s00247-022-05480-x] [Reference Citation Analysis]
2 Cisneros-garza L, González-huezo M, Moctezuma-velázquez C, Ladrón de Guevara-cetina L, Vilatobá M, García-juárez I, Alvarado-reyes R, Álvarez-treviño G, Allende-pérez S, Bornstein-quevedo L, Calderillo-ruiz G, Carrillo-martínez M, Castillo-barradas M, Cerda-reyes E, Félix-leyva J, Gabutti-thomas J, Guerrero-ixtlahuac J, Higuera-de-la-tijera F, Huitzil-meléndez D, Kimura-hayama E, López-hernández P, Malé-velázquez R, Méndez-sánchez N, Morales-ruiz M, Ruíz-garcía E, Sánchez-ávila J, Torrecillas-torres L. The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosis. Revista de Gastroenterología de México (English Edition) 2022. [DOI: 10.1016/j.rgmxen.2021.10.009] [Reference Citation Analysis]
3 Mürtz P, Mesropyan N, Sprinkart AM, Block W, Luetkens JA, Attenberger U, Pieper CC. Simplified intravoxel incoherent motion diffusion-weighted MRI of liver lesions: feasibility of combined two-colour index maps. Eur Radiol Exp 2021;5:33. [PMID: 34368913 DOI: 10.1186/s41747-021-00233-1] [Reference Citation Analysis]
4 Dominguez A, Fino D, Spina JC, Moyano Brandi N, Capó J, Noceti M, Ariza PP, Moura Cunha G. Assessment of SE-MRE-derived shear stiffness at 3.0 Tesla for solid liver tumors characterization. Abdom Radiol (NY) 2021;46:1904-11. [PMID: 33098479 DOI: 10.1007/s00261-020-02828-5] [Reference Citation Analysis]
5 Kovac JD, Ivanovic A, Milovanovic T, Micev M, Alessandrino F, Gore RM. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation. Radiol Oncol 2021;55:130-43. [PMID: 33544992 DOI: 10.2478/raon-2021-0004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Cha DI, Choi GS, Kim YK, Kim JM, Kang TW, Song KD, Ahn SH. Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS. Eur Radiol 2020;30:3723-34. [DOI: 10.1007/s00330-020-06753-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Ding X, Xu H, Zhou J, Xu J, Mei H, Long Q, Wang Y. Reproducibility of normalized apparent diffusion coefficient measurements on 3.0-T diffusion-weighted imaging of normal pancreas in a healthy population. Medicine (Baltimore) 2019;98:e15104. [PMID: 30946375 DOI: 10.1097/MD.0000000000015104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hwang JA, Kim YK, Min JH, Song KD, Sohn I, Ahn HS. Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer. Acta Radiol 2019;60:441-50. [PMID: 30130970 DOI: 10.1177/0284185118788901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
9 Pankaj Jain T, Kan WT, Edward S, Fernon H, Kansan Naider R. Evaluation of ADCratio on liver MRI diffusion to discriminate benign versus malignant solid liver lesions. Eur J Radiol Open 2018;5:209-14. [PMID: 30480057 DOI: 10.1016/j.ejro.2018.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Yang HJ, Song JS, Choi EJ, Choi H, Yang JD, Moon WS. Hypovascular hypointense nodules in hepatobiliary phase without T2 hyperintensity: long-term outcomes and added value of DWI in predicting hypervascular transformation. Clinical Imaging 2018;50:123-9. [DOI: 10.1016/j.clinimag.2018.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mürtz P, Sprinkart AM, Reick M, Pieper CC, Schievelkamp AH, König R, Schild HH, Willinek WA, Kukuk GM. Accurate IVIM model-based liver lesion characterisation can be achieved with only three b-value DWI. Eur Radiol 2018;28:4418-28. [PMID: 29671057 DOI: 10.1007/s00330-018-5401-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
12 Taron J, Johannink J, Bitzer M, Nikolaou K, Notohamiprodjo M, Hoffmann R. Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management. Cancer Imaging 2018;18:10. [PMID: 29514710 DOI: 10.1186/s40644-018-0140-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
13 Ayuso C, Rimola J, Vilana R, Burrel M, Darnell A, García-Criado Á, Bianchi L, Belmonte E, Caparroz C, Barrufet M, Bruix J, Brú C. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol 2018;101:72-81. [PMID: 29571804 DOI: 10.1016/j.ejrad.2018.01.025] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 20.0] [Reference Citation Analysis]
14 Budjan J, Sauter EA, Zoellner FG, Lemke A, Wambsganss J, Schoenberg SO, Attenberger UI. Diffusion kurtosis imaging of the liver at 3 Tesla: in vivo comparison to standard diffusion-weighted imaging. Acta Radiol 2018;59:18-25. [PMID: 28454487 DOI: 10.1177/0284185117706608] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
15 Kambadakone AR, Fung A, Gupta RT, Hope TA, Fowler KJ, Lyshchik A, Ganesan K, Yaghmai V, Guimaraes AR, Sahani DV, Miller FH. LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Radiol (NY) 2018;43:56-74. [PMID: 28940042 DOI: 10.1007/s00261-017-1325-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
16 Kovač JD, Galun D, Đurić-Stefanović A, Lilić G, Vasin D, Lazić L, Mašulović D, Šaranović Đ. Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible? Acta Radiol 2017;58:1417-26. [PMID: 28350257 DOI: 10.1177/0284185117695666] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
17 Liang M, Chen X, Xue F, Meng L, Cong Y. Diffusion-weighted imaging of injuries to the visual centers of the brain in patients with type 2 diabetes and retinopathy. Exp Ther Med 2017;14:1153-6. [PMID: 28810572 DOI: 10.3892/etm.2017.4582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Wu H, Zhang S, Liang C, Liu H, Liu Y, Mei Y, Liu H, Liu Z, Xu F. Intravoxel incoherent motion MRI for the differentiation of benign, intermediate, and malignant solid soft-tissue tumors: IVIM for Solid Soft-Tissue Tumors. J Magn Reson Imaging 2017;46:1611-8. [DOI: 10.1002/jmri.25733] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
19 Ishii S, Hara T, Nanbu T, Suenaga H, Sugawara S, Kuroiwa D, Sekino H, Miyajima M, Kubo H, Oriuchi N, Ito H. Optimized workflow and imaging protocols for whole-body oncologic PET/MRI. Jpn J Radiol 2016;34:754-62. [PMID: 27714486 DOI: 10.1007/s11604-016-0584-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Sutter O, Soyer P, Shotar E, Dautry R, Guerrache Y, Placé V, Opréa R, Ricbourg A, Le Dref O, Boudiaf M, Sirol M, Dohan A. Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization. Eur Radiol 2016;26:3558-70. [DOI: 10.1007/s00330-016-4210-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Mannelli L, Nougaret S, Vargas HA, Do RK. Advances in diffusion-weighted imaging. Radiol Clin North Am. 2015;53:569-581. [PMID: 25953290 DOI: 10.1016/j.rcl.2015.01.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
22 Fattach HE, Dohan A, Guerrache Y, Dautry R, Boudiaf M, Hoeffel C, Soyer P. Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imaging. Eur J Radiol 2015;84:1444-51. [PMID: 26022518 DOI: 10.1016/j.ejrad.2015.05.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
23 Hwang J, Kim YK, Jeong WK, Choi D, Rhim H, Lee WJ. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization. Radiology. 2015;276:137-146. [PMID: 25734551 DOI: 10.1148/radiol.15141350] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
24 Namimoto T, Nakagawa M, Kizaki Y, Itatani R, Kidoh M, Utsunomiya D, Oda S, Yamashita Y. Characterization of Liver Tumors by Diffusion-Weighted Imaging: Comparison of Diagnostic Performance Using the Mean and Minimum Apparent Diffusion Coefficient. Journal of Computer Assisted Tomography 2015;39:453-61. [DOI: 10.1097/rct.0000000000000228] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
25 Kwon S, Kim YK, Park HJ, Jeong WK, Lee WJ, Choi D. Is gadoxetic acid-enhanced MRI limited in tumor characterization for patients with chronic liver disease? Magnetic Resonance Imaging 2014;32:1214-22. [DOI: 10.1016/j.mri.2014.08.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Lamba R, Fananazapir G, Corwin MT, Khatri VP. Diagnostic Imaging of Hepatic Lesions in Adults. Surgical Oncology Clinics of North America 2014;23:789-820. [DOI: 10.1016/j.soc.2014.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
27 Mungai F, Morone M, Villanacci A, Bondioni MP, Mazzoni LN, Grazioli L, Colagrande S. Diffusion weighted MR and apparent diffusion coefficient measurement in classification and characterization of noncystic focal liver lesions: does a clinical role exist? Medicine (Baltimore) 2014;93:e40. [PMID: 25058143 DOI: 10.1097/MD.0000000000000040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
28 Stankovic Z, Fink J, Collins JD, Semaan E, Russe MF, Carr JC, Markl M, Langer M, Jung B. K-t GRAPPA-accelerated 4D flow MRI of liver hemodynamics: influence of different acceleration factors on qualitative and quantitative assessment of blood flow. MAGMA. 2015;28:149-159. [PMID: 25099493 DOI: 10.1007/s10334-014-0456-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
29 Schmid-tannwald C, Rist C. Re: Role of diffusion-weighted MRI in differentiation of hepatic abscesses from non-infected fluid collections. A reply. Clinical Radiology 2014;69:e371. [DOI: 10.1016/j.crad.2014.04.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Lee JM, Yoon JH, Joo I, Woo HS. Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma. Liver Cancer. 2012;1:22-40. [PMID: 24159569 DOI: 10.1159/000339018] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
31 Doblas S, Wagner M, Leitao HS, Daire JL, Sinkus R, Vilgrain V, Van Beers BE. Determination of malignancy and characterization of hepatic tumor type with diffusion-weighted magnetic resonance imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived measurements. Invest Radiol. 2013;48:722-728. [PMID: 23669588 DOI: 10.1097/rli.0b013e3182915912] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
32 Jhaveri K. Image quality versus outcomes. J Magn Reson Imaging 2015;41:866-9. [PMID: 24677391 DOI: 10.1002/jmri.24622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Dohan A, Soyer P, Guerrache Y, Hoeffel C, Gavini JP, Kaci R, Boudiaf M. Focal nodular hyperplasia of the liver: diffusion-weighted magnetic resonance imaging characteristics using high b values. J Comput Assist Tomogr 2014;38:96-104. [PMID: 24424559 DOI: 10.1097/RCT.0b013e3182a91006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
34 Chen X, Qin L, Pan D, Huang Y, Yan L, Wang G, Liu Y, Liang C, Liu Z. Liver diffusion-weighted MR imaging: reproducibility comparison of ADC measurements obtained with multiple breath-hold, free-breathing, respiratory-triggered, and navigator-triggered techniques. Radiology. 2014;271:113-125. [PMID: 24475860 DOI: 10.1148/radiol.13131572] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
35 Kim YK, Kim YK, Park HJ, Park MJ, Lee WJ, Choi D. Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma. Magn Reson Imaging. 2014;32:610-618. [PMID: 24702980 DOI: 10.1016/j.mri.2013.12.021] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
36 Zhou IY, Gao DS, Chow AM, Fan S, Cheung MM, Ling C, Liu X, Cao P, Guo H, Man K, Wu EX. Effect of diffusion time on liver DWI: An experimental study of normal and fibrotic livers: Effects of Diffusion Time on Liver DWI. Magn Reson Med 2014;72:1389-96. [DOI: 10.1002/mrm.25035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
37 Alıcıoglu B, Guler O, Bulakbası N, Akpınar S, Tosun O, Comunoglu C. Utility of semiquantitative parameters to differentiate benign and malignant focal hepatic lesions. Clinical Imaging 2013;37:692-6. [DOI: 10.1016/j.clinimag.2013.01.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
38 Barral M, Sebbag-sfez D, Hoeffel C, Chaput U, Dohan A, Eveno C, Boudiaf M, Soyer P. Caractérisation des lésions pancréatiques focales par la mesure du coefficient de diffusion apparent en IRM à 1,5 tesla : expérience préliminaire. Journal de Radiologie Diagnostique et Interventionnelle 2013;94:636-44. [DOI: 10.1016/j.jradio.2012.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Soyer P, Kanematsu M, Taouli B, Koh D, Manfredi R, Vilgrain V, Hoeffel C, Guiu B. ADC normalization: A promising research track for diffusion-weighted MR imaging of the abdomen. Diagnostic and Interventional Imaging 2013;94:571-3. [DOI: 10.1016/j.diii.2013.05.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
40 Penner AH, Sprinkart AM, Kukuk GM, Gütgemann I, Gieseke J, Schild HH, Willinek WA, Mürtz P. Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI. Eur Radiol. 2013;23:2773-2783. [PMID: 23666233 DOI: 10.1007/s00330-013-2869-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
41 Barral M, Sebbag-Sfez D, Hoeffel C, Chaput U, Dohan A, Eveno C, Boudiaf M, Soyer P. Characterization of focal pancreatic lesions using normalized apparent diffusion coefficient at 1.5-Tesla: preliminary experience. Diagn Interv Imaging. 2013;94:619-627. [PMID: 23545001 DOI: 10.1016/j.diii.2013.02.011] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
42 Barral M, Soyer P, Ben Hassen W, Gayat E, Aout M, Chiaradia M, Rahmouni A, Luciani A. Diffusion-weighted MR imaging of the normal pancreas: reproducibility and variations of apparent diffusion coefficient measurement at 1.5- and 3.0-Tesla. Diagn Interv Imaging. 2013;94:418-427. [PMID: 23415463 DOI: 10.1016/j.diii.2012.12.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
43 Colagrande S, Mazzoni LN, Mazzoni E, Pradella S. Effects of gadoxetic acid on quantitative diffusion-weighted imaging of the liver. J Magn Reson Imaging. 2013;38:365-370. [PMID: 23239165 DOI: 10.1002/jmri.23978] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
44 Hansmann J, Hernando D, Reeder SB. Fat confounds the observed apparent diffusion coefficient in patients with hepatic steatosis. Magn Reson Med. 2013;69:545-552. [PMID: 23161434 DOI: 10.1002/mrm.24535] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
45 Culverwell AD, Sheridan MB, Guthrie JA, Scarsbrook AF. Diffusion-weighted MRI of the liver-Interpretative pearls and pitfalls. Clin Radiol. 2013;68:406-414. [PMID: 22981728 DOI: 10.1016/j.crad.2012.08.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
46 Martinez-möller A, Eiber M, Nekolla SG, Souvatzoglou M, Drzezga A, Ziegler S, Rummeny EJ, Schwaiger M, Beer AJ. Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology. J Nucl Med 2012;53:1415-26. [DOI: 10.2967/jnumed.112.109348] [Cited by in Crossref: 87] [Cited by in F6Publishing: 62] [Article Influence: 8.7] [Reference Citation Analysis]